Cellebrite DI (CLBT) - Total Liabilities

Latest as of December 2025: $454.53 Million USD

Based on the latest financial reports, Cellebrite DI (CLBT) has total liabilities worth $454.53 Million USD as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Cellebrite DI - Total Liabilities Trend (2019–2025)

This chart illustrates how Cellebrite DI's total liabilities have evolved over time, based on quarterly financial data. See CLBT working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Cellebrite DI Competitors by Total Liabilities

The table below lists competitors of Cellebrite DI ranked by their total liabilities.

Company Country Total Liabilities
Growthpoint Properties Ltd
JSE:GRT
South Africa ZAC69.92 Billion
Dana Inc
NYSE:DAN
USA $6.89 Billion
Hyundai Steel
KO:004020
Korea ₩14.60 Trillion
Jiangsu Changshu Rural Commercial Bank Co Ltd
SHG:601128
China CN¥369.64 Billion
Jilin Power Share Co Ltd
SHE:000875
China CN¥60.72 Billion
Qingdao Gon Technology Co Ltd
SHE:002768
China CN¥12.38 Billion
Shufersal
TA:SAE
Israel ILA11.23 Billion
Zhejiang Huahai Pharmaceutical Co Ltd
SHG:600521
China CN¥12.36 Billion

Liability Composition Analysis (2019–2025)

This chart breaks down Cellebrite DI's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see CLBT company net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.56 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.94 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.48 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Cellebrite DI's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Cellebrite DI (2019–2025)

The table below shows the annual total liabilities of Cellebrite DI from 2019 to 2025.

Year Total Liabilities Change
2025-12-31 $454.53 Million +28.20%
2024-12-31 $354.55 Million -28.90%
2023-12-31 $498.67 Million +51.38%
2022-12-31 $329.43 Million -20.26%
2021-12-31 $413.13 Million +37.44%
2020-12-31 $300.58 Million +35.76%
2019-12-31 $221.41 Million --

About Cellebrite DI

NASDAQ:CLBT USA Software - Infrastructure
Market Cap
$3.11 Billion
Market Cap Rank
#4907 Global
#1612 in USA
Share Price
$12.47
Change (1 day)
-2.65%
52-Week Range
$11.03 - $19.56
All Time High
$26.00
About

Cellebrite DI Ltd. develops software and services for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company provides a platform of software solutions used to access, collect, review, extract, decode, decrypt, analyze, share and manage digital evidence across the investigative lifecycle for a range of investigations, such as child exp… Read more